Showing posts with label Nitric Oxide Symposium. Show all posts
Showing posts with label Nitric Oxide Symposium. Show all posts

Wednesday, June 23, 2010

Post-Event: MaRS Discovery District: Nitric Oxide Symposium

Thank you again to the wonderful folk at MaRS Discovery District and at NeurAxon for their fantastic work during the recent Nitric Oxide and other Gaseous Neurotransmitter (NOX) Symposium. The gathering of 20 of the leading minds in the field, including Noble Laureate Dr. Ferid Murad, was the first of it's kind in Toronto-are we next in line for the crown of Canada's premiere BioTech city? I hope so--if only to have more quality Symposiums such as NOX, and in order for there to be opportunity for me to work with this great collection of people again!

For more information on MaRS Discovery District and the amazing work they do there please visit www.marsdd.com
The pioneering folk at NeurAxon can be found at www.neuraxon.com

Wednesday, March 24, 2010

MaRS Discovery District: Nitric Oxide Symposium

Type A Events is proud to be part of the coordination team for the Nitric Oxide Symposium presented by MaRS Discovery District and NeurAxon taking place on May 27th and 28th, 2010.

Following the Nobel Prize awarded in 1998 for the discovery and function of Nitric Oxide (which up until then had been regarded as a noxious gas) an enormous amount of research has been undertaken to better understand the functions of this neurotransmitter in various physiological conditions as well as acute and chronic pathological conditions such as pain, Parkinson’s disease, Alzheimer’s disease, traumatic brain injury, stroke, inflammatory disease etc. Apart from Nitric Oxide, two other gaseous neurotransmitters, Hydrogen Sulfide and Carbon Monoxide, have become the focus of biologists and chemists alike to explore the significance of these neurotransmitters in inflammation and gastric mucosal protection.

The objective of this symposium is to increase awareness amongst the research community as to how basic science driven approaches can lead to the successful development of novel therapeutic agents.
The following aspects will be covered:
  • Biology: Discovery and function of gaseous neurotransmitters and mediators, including hydrogen sulfide and carbon monoxide
  • Pharmacology: Pain, inflammation, immunology, CNS, TBI
  • Structure: X-Ray structures on ligand bound enzymes
  • Chemistry: Donors and inhibitors - therapeutic implications
  • Clinical applications

For further information and registration please click here.